Determinants of alpha 2-adrenergic receptor activation of G proteins: evidence for a precoupled receptor/G protein state

WN Tian, E Duzic, SM Lanier and RC Deth

Department of Pharmaceutical Sciences, Northeastern University, Boston, Massachusetts 02115.

The ability of agonist-occupied alpha 2D-adrenergic receptors to activate G proteins was measured in membranes from PC-12 cells stably expressing the cloned receptor, using guanosine-5'-O-(3- [35S]thio)triphosphate ([35S]GTP gamma S) binding as an endpoint. Epinephrine (EPI) stimulated [35S]GTP gamma S binding in a Mg(2+)- dependent manner, showing both micromolar and millimolar cation affinities. Prior treatment of cells with pertussis toxin completely eliminated the EPI stimulation. The presence of GDP decreased basal [35S]GTP gamma S binding and increased the proportion of EPI-stimulated binding. Increasing concentrations of Na+ also reduced basal [35S]GTP gamma S binding but had less effect on EPI-stimulated binding, such that the agonist response was proportionately greater at higher Na+ levels. In saturation binding studies with [35S]GTP gamma S only low affinity binding was observed in the presence of 100 mM Na+, whereas in the absence of Na+ a high affinity component was also present, indicating a Na(+)-regulated receptor/G protein interaction. EPI induced high affinity [35S]GTP gamma S binding in the presence of Na+ and increased the affinity of the high affinity component under Na(+)- free conditions. The selective alpha 2-adrenergic antagonist rauwolscine produced rightward shifts of EPI dose-response curves and decreased the basal level of [35-S]GTP gamma S binding across the same range of concentrations. The extent of decrease was dependent upon the alpha 2-adrenergic receptor expression level, indicating that alpha 2- adrenergic receptors contribute to basal G protein activation in the absence of agonist. The ability of rauwolscine to decrease basal [35S]GTP gamma S binding was diminished as the level of Na+ was increased, suggesting that both agents act to reduce receptor/G protein interaction, by distinctive mechanisms. alpha 2-Adrenergic receptor antagonists reduced basal G protein activation with a rank order for maximal effectiveness that was different from their receptor binding affinities. These results support the existence of precoupling between alpha 2D-adrenergic receptors and G proteins; coupling can be diminished by both Na+ and antagonists, whereas agonists increase the efficiency of receptor/G protein coupling.

Volume 45, Issue 3, pp. 524-531, 03/01/1994
Copyright © 1994 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				Z. Liao, C. I. Seye, G. A. Weisman, and L. Erb The P2Y2 nucleotide receptor requires interaction with {alpha}v integrins to access and activate G12 J. Cell Sci., May 1, 2007; 120(9): 1654 - 1662. [Abstract] [Full Text] [PDF]

				M. Nobles, A. Benians, and A. Tinker Heterotrimeric G proteins precouple with G protein-coupled receptors in living cells PNAS, December 20, 2005; 102(51): 18706 - 18711. [Abstract] [Full Text] [PDF]

				S. Bagchi, Z. Liao, F. A. Gonzalez, N. E. Chorna, C. I. Seye, G. A. Weisman, and L. Erb The P2Y2 Nucleotide Receptor Interacts with {alpha}v Integrins to Activate Go and Induce Cell Migration J. Biol. Chem., November 25, 2005; 280(47): 39050 - 39057. [Abstract] [Full Text] [PDF]

				A. Benians, M. Nobles, S. Hosny, and A. Tinker Regulators of G-protein Signaling Form a Quaternary Complex with the Agonist, Receptor, and G-protein: A NOVEL EXPLANATION FOR THE ACCELERATION OF SIGNALING ACTIVATION KINETICS J. Biol. Chem., April 8, 2005; 280(14): 13383 - 13394. [Abstract] [Full Text] [PDF]

				T. Kenakin Efficacy as a Vector: the Relative Prevalence and Paucity of Inverse Agonism Mol. Pharmacol., January 1, 2004; 65(1): 2 - 11. [Abstract] [Full Text] [PDF]

				R. Seifert Monovalent Anions Differentially Modulate Coupling of the beta 2-Adrenoceptor to Gsalpha Splice Variants J. Pharmacol. Exp. Ther., August 1, 2001; 298(2): 840 - 847. [Abstract] [Full Text] [PDF]

				A. Alt, I. J. McFadyen, C. D. Fan, J. H. Woods, and J. R. Traynor Stimulation of Guanosine-5'-O-(3-[35S]thio)triphosphate Binding in Digitonin-Permeabilized C6 Rat Glioma Cells: Evidence for an Organized Association of {micro}-Opioid Receptors and G Protein J. Pharmacol. Exp. Ther., July 1, 2001; 298(1): 116 - 121. [Abstract] [Full Text]

				T. KENAKIN Inverse, protean, and ligand-selective agonism: matters of receptor conformation FASEB J, March 1, 2001; 15(3): 598 - 611. [Abstract] [Full Text] [PDF]

				S. M. Wade, K.-L. Lan, D. J. Moore, and R. R. Neubig Inverse Agonist Activity at the {alpha}2A-Adrenergic Receptor Mol. Pharmacol., March 1, 2001; 59(3): 532 - 542. [Abstract] [Full Text]

				P. J. Pauwels, S. Tardif, T. Wurch, and F. C. Colpaert Facilitation of Constitutive alpha 2A-Adrenoceptor Activity by Both Single Amino Acid Mutation (Thr373Lys) and Galpha o Protein Coexpression: Evidence for Inverse Agonism J. Pharmacol. Exp. Ther., February 1, 2000; 292(2): 654 - 663. [Abstract] [Full Text]

				W.-N. Tian, D. D. Miller, and R. C. Deth Bidirectional Allosteric Effects of Agonists and GTP at alpha 2A/D-Adrenoceptors J. Pharmacol. Exp. Ther., February 1, 2000; 292(2): 664 - 671. [Abstract] [Full Text]

				G. Chen, J. Way, S. Armour, C. Watson, K. Queen, C. K. Jayawickreme, W.-J. Chen, and T. Kenakin Use of Constitutive G Protein-Coupled Receptor Activity for Drug Discovery Mol. Pharmacol., January 1, 2000; 57(1): 125 - 134. [Abstract] [Full Text]

				R. M. Quock, T. H. Burkey, E. Varga, Y. Hosohata, K. Hosohata, S. M. Cowell, C. A. Slate, F. J. Ehlert, W. R. Roeske, and H. I. Yamamura The delta -Opioid Receptor: Molecular Pharmacology, Signal Transduction, and the Determination of Drug Efficacy Pharmacol. Rev., September 1, 1999; 51(3): 503 - 532. [Abstract] [Full Text] [PDF]

				H. K. Happe, D. B. Bylund, and L. C. Murrin Alpha-2 Adrenergic Receptor Functional Coupling to G Proteins in Rat Brain During Postnatal Development J. Pharmacol. Exp. Ther., March 1, 1999; 288(3): 1134 - 1142. [Abstract] [Full Text]

				A. E. Remmers, M. J. Clark, A. Mansour, H. Akil, J. H. Woods, and F. Medzihradsky Opioid Efficacy in a C6 Glioma Cell Line Stably Expressing the Human Kappa Opioid Receptor J. Pharmacol. Exp. Ther., February 1, 1999; 288(2): 827 - 833. [Abstract] [Full Text]

				A. E. Remmers, M. J. Clark, X. Y. Liu, and F. Medzihradsky Delta Opioid Receptor Down-Regulation Is Independent of Functional G Protein yet Is Dependent on Agonist Efficacy J. Pharmacol. Exp. Ther., November 1, 1998; 287(2): 625 - 632. [Abstract] [Full Text]

				E. S. Burstein, T. A. Spalding, and M. R. Brann The Second Intracellular Loop of the m5 Muscarinic Receptor Is the Switch Which Enables G-protein Coupling J. Biol. Chem., September 18, 1998; 273(38): 24322 - 24327. [Abstract] [Full Text] [PDF]

				K. Wenzel-Seifert, C. M. Hurt, and R. Seifert High Constitutive Activity of the Human Formyl Peptide Receptor J. Biol. Chem., September 11, 1998; 273(37): 24181 - 24189. [Abstract] [Full Text] [PDF]

				A. Alt, A. Mansour, H. Akil, F. Medzihradsky, J. R. Traynor, and J. H. Woods Stimulation of Guanosine-5'-O-(3-[35S]Thio)Triphosphate Binding by Endogenous Opioids Acting at a Cloned Mu Receptor J. Pharmacol. Exp. Ther., July 1, 1998; 286(1): 282 - 288. [Abstract] [Full Text]

				D. E. Selley, Q. Liu, and S. R. Childers Signal Transduction Correlates of Mu Opioid Agonist Intrinsic Efficacy: Receptor-Stimulated [35S]GTPgamma S Binding in mMOR-CHO Cells and Rat Thalamus J. Pharmacol. Exp. Ther., May 1, 1998; 285(2): 496 - 505. [Abstract] [Full Text]

				C. C. Jansson, J. P. Kukkonen, J. Näsman, G. Huifang, S. Wurster, R. Virtanen, J.-M. Savola, V. Cockcroft, and K. E. O. Åkerman Protean Agonism at alpha 2A-Adrenoceptors Mol. Pharmacol., May 1, 1998; 53(5): 963 - 968. [Abstract] [Full Text]

				G.-R. Wang, Y. Zhu, P. V. Halushka, T. M. Lincoln, and M. E. Mendelsohn Mechanism of platelet inhibition by nitric oxide: In vivo phosphorylation of thromboxane receptor by cyclic GMP-dependent protein kinase PNAS, April 28, 1998; 95(9): 4888 - 4893. [Abstract] [Full Text] [PDF]

				A. J. Barr and D. R. Manning Agonist-independent Activation of Gz by the 5-Hydroxytryptamine1A Receptor Co-expressed in Spodoptera frugiperda Cells. DISTINGUISHING INVERSE AGONISTS FROM NEUTRAL ANTAGONISTS J. Biol. Chem., December 26, 1997; 272(52): 32979 - 32987. [Abstract] [Full Text] [PDF]

				P. G. Szekeres and J. R. Traynor Delta Opioid Modulation of the Binding of Guanosine-5'-O-(3-[35S]thio)triphosphate to NG108-15 Cell Membranes: Characterization of Agonist and Inverse Agonist Effects J. Pharmacol. Exp. Ther., December 1, 1997; 283(3): 1276 - 1284. [Abstract] [Full Text]

				M. J. Clark, P. J. Emmerson, A. Mansour, H. Akil, J. H. Woods, P. S. Portoghese, A. E. Remmers, and F. Medzihradsky Opioid Efficacy in a C6 Glioma Cell Line Stably Expressing the Delta Opioid Receptor J. Pharmacol. Exp. Ther., November 1, 1997; 283(2): 501 - 510. [Abstract] [Full Text]

				A. Wise and G. Milligan Rescue of Functional Interactions between the alpha 2A-Adrenoreceptor and Acylation-resistant Forms of Gi1alpha by Expressing the Proteins from Chimeric Open Reading Frames J. Biol. Chem., September 26, 1997; 272(39): 24673 - 24678. [Abstract] [Full Text] [PDF]

				J. Zhu, L.-Y. Luo, J.-G. Li, C. Chen, and L.-Y. Liu-Chen Activation of the Cloned Human Kappa Opioid Receptor by Agonists Enhances [35S]GTPgamma S Binding to Membranes: Determination of Potencies and Efficacies of Ligands J. Pharmacol. Exp. Ther., August 1, 1997; 282(2): 676 - 684. [Abstract] [Full Text]

				A. Newman-Tancredi, V. Audinot, C. Chaput, and L.V. a. M. J. Millan [35S]Guanosine-5'-O-(3-thio)triphosphate Binding as a Measure of Efficacy at Human Recombinant Dopamine D4.4 Receptors: Actions of Antiparkinsonian and Antipsychotic Agents J. Pharmacol. Exp. Ther., July 1, 1997; 282(1): 181 - 191. [Abstract] [Full Text]

				A. Jinsi-Parimoo and R. C. Deth Reconstitution of alpha 2D-Adrenergic Receptor Coupling to Phospholipase D in a PC12 Cell Lysate J. Biol. Chem., June 6, 1997; 272(23): 14556 - 14561. [Abstract] [Full Text] [PDF]

				A. J. Williams, A. D. Michel, W. Feniuk, and P. P. A. Humphrey Somatostatin5 Receptor-Mediated [35S]Guanosine-5'-O-(3-thio)triphosphate Binding: Agonist Potencies and the Influence of Sodium Chloride on Intrinsic Activity Mol. Pharmacol., June 1, 1997; 51(6): 1060 - 1069. [Abstract] [Full Text]

				K. M. Ella, C. Qi, A. F. McNair, J.-H. Park, A. E. Wisehart-Johnson, and K. E. Meier Phospholipase D Activity in PC12 Cells. EFFECTS OF OVEREXPRESSION OF alpha 2A-ADRENERGIC RECEPTORS J. Biol. Chem., May 16, 1997; 272(20): 12909 - 12912. [Abstract] [Full Text] [PDF]

				E. S. Burstein, T. A. Spalding, and M. R. Brann Pharmacology of Muscarinic Receptor Subtypes Constitutively Activated by G Proteins Mol. Pharmacol., February 1, 1997; 51(2): 312 - 319. [Abstract] [Full Text] [PDF]

				M. Sato, R. Kataoka, J. Dingus, M. Wilcox, J. D. Hildebrandt, and S. M. Lanier Factors Determining Specificity of Signal Transduction by G-protein-coupled Receptors J. Biol. Chem., June 23, 1995; 270(25): 15269 - 15276. [Abstract] [Full Text] [PDF]

				F. Meng, Q. Wei, M. T. Hoversten, L. P. Taylor, and H. Akil Switching Agonist/Antagonist Properties of Opiate Alkaloids at the delta Opioid Receptor Using Mutations Based on the Structure of the Orphanin FQ Receptor J. Biol. Chem., July 14, 2000; 275(29): 21939 - 21945. [Abstract] [Full Text] [PDF]